Australian Alzheimer’s study
A major Australian study to better understand Alzheimer's disease has started.
The $10 million Australian Imaging, Biomarker and Lifestyle (AIBL) Flagship Study of Ageing has brought together leading Australian researchers for a three-year study to improve understanding of the causes and diagnosis of the disease, to examine lifestyle and diet factors that may influence the onset of Alzheimer's and to help develop preventative strategies.
It will be one of the world's largest studies of its type involving positron emission tomography (PET) scans using Pittsburgh Compound-B (PIB), a PET amyloid-imaging agent. The scans are used to show differences between the brains of Alzheimer's patients and healthy volunteers.
The study was established by the CSIRO-led Preventative Health National Research Flagship, and involves Edith Cowan University, the University of Melbourne, Neurosciences Australia and the Mental Health Research Institute of Victoria.
7th edition of STEM Equity Monitor now available
The latest national data resource on diversity in STEM has new design features intended to...
Professor Girish Dwivedi wins 2026 WA Pearcey Entrepreneur of the Year Award
As part of the 35th annual WAITTA INCITE Awards, Dwivedi was recognised for his contribution to...
Monash University signs MOU with TGA Academic Outreach Program
The program fosters collaboration across research, knowledge exchange and education to support...
